Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liora M Schultz

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Transplantation and Cellular Therapy|July 22, 2023
INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic LeukemiaRegina M Myers, Elad Jacoby, Michael A Pulsipher, et al.
Transplantation and Cellular Therapy|October 20, 2023
INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies-Established Findings and Future PrioritiesJohn A Ligon, Sneha Ramakrishna, Francesco Ceppi, et al.
Blood Advances|May 3, 2024
Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adultsAdam J Lamble, Liora M Schultz, Khanh Nguyen, et al.
Pediatric Blood & Cancer|January 23, 2025
Access to CARe: A Narrative of Real-World Medical Decision-Making to Access Chimeric Antigen Receptor (CAR) T-Cell Therapy in Children, Adolescents, and Young AdultsAngela Steineck, Karen Chao, Anurekha G Hall, et al.
Transplantation and Cellular Therapy|October 2, 2025
Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell ProvidersKevin O McNerney, Caroline Diorio, Colleen Annesley, et al.
The American Journal of Surgical Pathology|August 24, 2022
Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell LymphomasKunwar Singh, Lhara S Lezama, Jason Kurzer, et al.
Blood Advances|June 25, 2024
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomasJonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, et al.
Blood Cancer Discovery|December 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeHrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPETFederico Simonetta, Israt S Alam, Juliane K Lohmeyer, et al.
Eclinicalmedicine|November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patternsValentin Barsan, Yimei Li, Snehit Prabhu, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Transplantation and Cellular Therapy|July 22, 2023
INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic LeukemiaRegina M Myers, Elad Jacoby, Michael A Pulsipher, et al.
Transplantation and Cellular Therapy|October 20, 2023
INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies-Established Findings and Future PrioritiesJohn A Ligon, Sneha Ramakrishna, Francesco Ceppi, et al.
Blood Advances|May 3, 2024
Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adultsAdam J Lamble, Liora M Schultz, Khanh Nguyen, et al.
Pediatric Blood & Cancer|January 23, 2025
Access to CARe: A Narrative of Real-World Medical Decision-Making to Access Chimeric Antigen Receptor (CAR) T-Cell Therapy in Children, Adolescents, and Young AdultsAngela Steineck, Karen Chao, Anurekha G Hall, et al.
Transplantation and Cellular Therapy|October 2, 2025
Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell ProvidersKevin O McNerney, Caroline Diorio, Colleen Annesley, et al.
The American Journal of Surgical Pathology|August 24, 2022
Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell LymphomasKunwar Singh, Lhara S Lezama, Jason Kurzer, et al.
Blood Advances|June 25, 2024
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomasJonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, et al.
Blood Cancer Discovery|December 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeHrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPETFederico Simonetta, Israt S Alam, Juliane K Lohmeyer, et al.
Eclinicalmedicine|November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patternsValentin Barsan, Yimei Li, Snehit Prabhu, et al.
Pageof 4